Skip to content
Tariffs and dutiesCBPUnited StatesImportsExports

Updated guidance: Section 232 Duties on Imports of Pharmaceutical Articles and Ingredients

28 September 2026

In plain English

CSMS #70054007 updates CBP guidance on Section 232 duties under Proclamation 11020 for pharmaceutical articles and ingredients, reflecting the September 23, 2026 Federal Register notice and related HTSUS corrections.

Read the official notice
Topic
Tariffs and duties
Regulator
CBP
Published
28 September 2026
For
Imports and Exports
Where it applies
United States
Source
CBP CSMS

From the notice

This message provides updated guidance regarding the implementation of Proclamation 11020, "Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States," dated April 2, 2026 and the September 23, 2026 Federal Register notice on Guidance and Procedures for Implementing Tariff Adjustments for Specialty Pharmaceuticals and Associated Pharmaceutical Ingredients and Technical Corrections to the Harmonized Tariff Schedule of the United States for Duties Imposed Under Proclamation 11020 (91 FR 60360). BACKGROUND On April 2, 2026, the President issued Proclamation 11020, imposing additional duties on certain imports of patented
The full text is at the source

Olive tells you which of these hit your products.

Olive reads every change like these against your own products, codes and trade lanes, whether you import, export or both, and drafts the update to your compliance program for your approval. Nothing changes without you.

Get startedLive demo

Olivra lists official notices for information only. It is not legal advice, and Olive is not a lawyer or a licensed customs broker. The official text at the source is what counts.

More from CBP

See everything Olive monitors